Compared side by side
Clomiphene vs enclomiphene: how they differ
The short answer
Enclomiphene is the purified trans isomer of clomiphene: clomiphene citrate is a mix of enclomiphene, the part that drives LH up, and zuclomiphene (30–50% of the drug), which has more estrogen-like activity and lingers in the body for over a month. Both are oral SERMs (not peptides) that block estrogen’s feedback in the brain, so the body makes more of its own LH and FSH and, in men, testosterone. Clomiphene is FDA-approved, as Clomid, for ovulation problems in women, and its use in men is off-label; enclomiphene has no FDA-approved product, and the EU refused it in 2018.
Side by side
| Compared | Clomiphene | Enclomiphene |
|---|---|---|
| Category | Sexual health | Sexual health |
| Also known as | Clomid, Clomiphene citrate, Clomifene, Serophene, Milophene, CC | Androxal, Trans-clomiphene, Enclomiphene citrate |
| What it is | An oral pill that blocks estrogen's signal in the brain, so the body makes more of its own LH and FSH, and with them testosterone and sperm. | An oral medication that blocks estrogen's negative feedback at the hypothalamus, tricking your brain into producing more LH and FSH — which stimulates your body's own testosterone production. |
| How it works | A selective estrogen receptor modulator (SERM), not a peptide. It blocks estrogen's feedback signal at the hypothalamus and pituitary, so the brain reads estrogen as low and sends out more LH and FSH; in men that raises the testes' own testosterone and supports sperm production, the opposite of TRT, which shuts both down. Clomiphene citrate is a mix of two isomers: enclomiphene (trans), the part that drives LH up, and zuclomiphene (cis, 30–50% of the drug), which has more estrogen-like activity and lingers in the body for over a month. FDA-approved only for ovulation problems in women; its use in men is off-label. | Selective estrogen receptor modulator (SERM) and the pure trans-isomer of clomiphene. Blocks estrogen negative feedback at the hypothalamus, increasing LH and FSH production which stimulates endogenous testosterone production. Designed to cause fewer estrogenic side effects than clomifene citrate, since it lacks the estrogenic zuclomiphene isomer (no head-to-head trial). SERM, not a peptide — included as it is commonly used in hormonal optimization and TRT-adjacent protocols. |
| Commonly reported | More energy and libido over a few weeks, and in some, mood swings, hot flashes or visual spots, the side effect the label warns about. Enclomiphene is its purified active half. | Better energy and libido over a few weeks as testosterone rises, mood changes such as irritability in some, and occasional visual disturbances that make some people stop. Used as a TRT alternative or in post-cycle therapy (PCT) to restart natural testosterone. |
| Studied range | Research range: 25–50 mg. Studied in research — not a recommendation. FDA-approved (Clomid; generics) only for ovulatory dysfunction in women, 50–100 mg a day for 5-day courses; use in men is off-label. | Research range: 12.5–25 mg. Studied in research — not a recommendation. |
| How often | Daily or every other day | Daily |
| Half-life | ~5 days (community estimate; the label gives no number: zuclomiphene, the slower isomer, is still measurable in the blood over a month after a dose, enclomiphene clears faster) | ~10 hours |
| Route | Oral tablet | Oral |
| Typical run | For low testosterone, run continuously and checked with labs: men in clinic records have stayed on it for over 3 years (Moskovic 2012; Krzastek 2019). After a steroid cycle (post-cycle therapy, PCT), courses commonly run 4–8 weeks; one clinic's cohort ran 25 mg a day until recovery (İbis 2026). In women, the label limits it to 5-day courses, about six cycles in all. | Daily oral. Used for months in clinical context. Community uses in 3–6 month cycles. Also used as an alternative to TRT (its trials compared it with testosterone gel) and, in the community, after a steroid cycle (PCT). |
| Evidence | Moderate: animal studies + some human data | Moderate: animal studies + some human data |
| Common side effects | Mood changes or irritability, hot flashes, breast tenderness, blurred vision or visual spots (uncommon), headache, lower HDL cholesterol | Mood changes, visual disturbances (rare), hot flashes, blood-clot risk flagged by the EU regulator |
- Category
- ClomipheneSexual health
- EnclomipheneSexual health
- Also known as
- ClomipheneClomid, Clomiphene citrate, Clomifene, Serophene, Milophene, CC
- EnclomipheneAndroxal, Trans-clomiphene, Enclomiphene citrate
- What it is
- ClomipheneAn oral pill that blocks estrogen's signal in the brain, so the body makes more of its own LH and FSH, and with them testosterone and sperm.
- EnclomipheneAn oral medication that blocks estrogen's negative feedback at the hypothalamus, tricking your brain into producing more LH and FSH — which stimulates your body's own testosterone production.
- How it works
- ClomipheneA selective estrogen receptor modulator (SERM), not a peptide. It blocks estrogen's feedback signal at the hypothalamus and pituitary, so the brain reads estrogen as low and sends out more LH and FSH; in men that raises the testes' own testosterone and supports sperm production, the opposite of TRT, which shuts both down. Clomiphene citrate is a mix of two isomers: enclomiphene (trans), the part that drives LH up, and zuclomiphene (cis, 30–50% of the drug), which has more estrogen-like activity and lingers in the body for over a month. FDA-approved only for ovulation problems in women; its use in men is off-label.
- EnclomipheneSelective estrogen receptor modulator (SERM) and the pure trans-isomer of clomiphene. Blocks estrogen negative feedback at the hypothalamus, increasing LH and FSH production which stimulates endogenous testosterone production. Designed to cause fewer estrogenic side effects than clomifene citrate, since it lacks the estrogenic zuclomiphene isomer (no head-to-head trial). SERM, not a peptide — included as it is commonly used in hormonal optimization and TRT-adjacent protocols.
- Commonly reported
- ClomipheneMore energy and libido over a few weeks, and in some, mood swings, hot flashes or visual spots, the side effect the label warns about. Enclomiphene is its purified active half.
- EnclomipheneBetter energy and libido over a few weeks as testosterone rises, mood changes such as irritability in some, and occasional visual disturbances that make some people stop. Used as a TRT alternative or in post-cycle therapy (PCT) to restart natural testosterone.
- Studied range
- ClomipheneResearch range: 25–50 mg. Studied in research — not a recommendation. FDA-approved (Clomid; generics) only for ovulatory dysfunction in women, 50–100 mg a day for 5-day courses; use in men is off-label.
- EnclomipheneResearch range: 12.5–25 mg. Studied in research — not a recommendation.
- How often
- ClomipheneDaily or every other day
- EnclomipheneDaily
- Half-life
- Clomiphene~5 days (community estimate; the label gives no number: zuclomiphene, the slower isomer, is still measurable in the blood over a month after a dose, enclomiphene clears faster)
- Enclomiphene~10 hours
- Route
- ClomipheneOral tablet
- EnclomipheneOral
- Typical run
- ClomipheneFor low testosterone, run continuously and checked with labs: men in clinic records have stayed on it for over 3 years (Moskovic 2012; Krzastek 2019). After a steroid cycle (post-cycle therapy, PCT), courses commonly run 4–8 weeks; one clinic's cohort ran 25 mg a day until recovery (İbis 2026). In women, the label limits it to 5-day courses, about six cycles in all.
- EnclomipheneDaily oral. Used for months in clinical context. Community uses in 3–6 month cycles. Also used as an alternative to TRT (its trials compared it with testosterone gel) and, in the community, after a steroid cycle (PCT).
- Evidence
- ClomipheneModerate: animal studies + some human data
- EnclomipheneModerate: animal studies + some human data
- Common side effects
- ClomipheneMood changes or irritability, hot flashes, breast tenderness, blurred vision or visual spots (uncommon), headache, lower HDL cholesterol
- EnclomipheneMood changes, visual disturbances (rare), hot flashes, blood-clot risk flagged by the EU regulator
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Clomiphene
- Day 1–14 Your brain turns the signal up
- Day 1–56 Restarting after a steroid cycle
- Day 14–84 Testosterone settles at a new level
- Day 84–365 A long run, checked on labs
Enclomiphene
- Day 1–14 LH and FSH climbing, T follows
- Day 14–84 Steady-state testosterone
- Day 84–180 Long-term use assessment
Together or one or the other
Clomiphene and enclomiphene are a common stack: clomiphene lists enclomiphene among its common stacks.
Clinical · Clomiphene
The same drug, two halves
Enclomiphene is the half of clomiphene that raises LH; the other half, zuclomiphene, is more estrogen-like and lingers for weeks. Running both adds nothing new, which is why people pick one or the other.
Questions people ask
How long do clomiphene and enclomiphene last?
The half-life of clomiphene is ~5 days (community estimate; the label gives no number: zuclomiphene, the slower isomer, is still measurable in the blood over a month after a dose, enclomiphene clears faster). The half-life of enclomiphene is ~10 hours.
How often are clomiphene and enclomiphene taken?
Clomiphene: daily or every other day. Route: Oral tablet. Enclomiphene: daily. Route: Oral.
How are clomiphene and enclomiphene dosed in research?
The research range for clomiphene is 25–50 mg. Studied in research — not a recommendation. FDA-approved (Clomid; generics) only for ovulatory dysfunction in women, 50–100 mg a day for 5-day courses; use in men is off-label. The research range for enclomiphene is 12.5–25 mg. Studied in research — not a recommendation.
What are the common side effects of clomiphene and enclomiphene?
For clomiphene, the library lists: mood changes or irritability, hot flashes, breast tenderness, blurred vision or visual spots (uncommon), headache, lower HDL cholesterol. For enclomiphene: mood changes, visual disturbances (rare), hot flashes, blood-clot risk flagged by the EU regulator.
Are clomiphene and enclomiphene taken together?
Clomiphene and enclomiphene are a common stack: clomiphene lists enclomiphene among its common stacks. Enclomiphene is the half of clomiphene that raises LH; the other half, zuclomiphene, is more estrogen-like and lingers for weeks. Running both adds nothing new, which is why people pick one or the other.